NasdaqGS:AMLXPharmaceuticals
Assessing Amylyx Pharmaceuticals (AMLX) Valuation After Strong Recent Share Price Momentum
Amylyx Pharmaceuticals stock in focus
Amylyx Pharmaceuticals (AMLX) has drawn investor attention after recent trading, with the stock closing at US$16.46 and a market value of about US$1.78b, backed by a clinical stage pipeline in neurodegenerative and endocrine conditions.
See our latest analysis for Amylyx Pharmaceuticals.
The recent 2.81% 1 day share price return and 10.10% 30 day share price return sit alongside a 44.13% year to date share price return. The 1 year total shareholder return...